Organization: Health Canada
Year: 2023
Month: December
Request Number: A-2022-001356
Request Summary: Adverse Drug Reactions (ADRs) for MESALAZINE. Report numbers: E2B_05926116, E2B_05879303, E2B_05951268, 001018724, 001018203, 001018211, 001017894. ADRs for MESALAMINE. Report numbers: E2B_05929118, E2B_05960176. ADR for TEDUGLUTIDE. Report number: E2B_05932422.
Disposition: Disclosed in part
Number of pages: 309